2 articles in this volume
Urinary tract infections (UTIs) are among the most prevalent infectious diseases globally, impacting 150 million people annually, resulting in significant morbidity and high medical expenses. While the symptoms of UTIs can differ based on the location of these infections, they adversely affect patients' personal and social relationships, leading to diminished quality of life. In India, the prevalence of UTIs ranges from 21.8% to 31.3%.
Bacteria are the predominant causative agents responsible for UTIs, although more rarely, other microorganisms like fungi and certain viruses have also been identified. Uropathogenic E. coli (UPEC) is the most frequent cause of uncomplicated and complicated UTIs. Most UTIs are caused by Gram-negative and Gram-positive bacteria that reside in the colon, like E. coli, Enterococcus faecalis, Proteus mirabilis, and Klebsiella pneumoniae. Other pathogens, including Staphylococcus saprophyticus, Group B Streptococcus (GBS), and Pseudomonas aeruginosa, can also be responsible.
UTIs often begin when uropathogens from the gut colonize the urethra and later the bladder by specific adhesins. If the host's inflammatory response does not clear all bacteria, they proliferate, producing toxins and enzymes that facilitate their survival. Further colonization of the kidneys can lead to bacteremia if the pathogen crosses the kidney epithelial barrier. Bacterial proliferation can also result from biofilm protection, and if the infection remains untreated, it can lead to pyelonephritis and bacteremia.
Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland, common in older men, and a leading cause of lower urinary tract symptoms (LUTS). Its prevalence increases with age, affecting up to 60% of men in their 60s and nearly 90% of those over 70. BPH involves histological changes, while benign prostatic enlargement (BPE) refers to the increased size of the prostate, often leading to bladder outlet obstruction (BOO). This results from cell proliferation in the prostate's transition zone, causing urethral compression and urinary issues. Treatment ranges from watchful waiting to medical and surgical interventions, with risk factors including age, genetics, and lifestyle factors such as obesity.